This is a summary of the webinar conducted on September 16, 2020 on how a proven care program can help with weight loss and aid in the reversal of comorbidities, particularly in the context of COVID-19.
The rapid spread of COVID-19 across the globe has been aided by an underlying and already present epidemic, Obesity. Obesity and overweight-related illnesses are a major risk factor for the severity of COVID, the comorbidities, and the mortality rates associated with it. In fact, Obesity is a major risk factor for the hospitalization of COVID patients, compared to diabetes, heart failure, smoker status, or kidney failure.
Obesity and overweight-related health issues adversely impact the digestive, cardiovascular as well as musculoskeletal systems too. Having diabetes and/or hypertension worsens the situation further.
As Obesity stems from metabolic issues that can be traced back to an individual’s genetic make-up, lifestyle patterns, and gut microbial composition, managing these parameters is vital to weight reduction and management. Digbi’s Proven Care Program is designed based on these key parameters and has been showing great results.
Evidence suggests that the best way to manage and reverse weight-related comorbidities and chronic inflammatory conditions within these systems is to reverse the underlying agent, Obesity itself. The best way to achieve this is through steady, healthy, and sustainable weight loss. Digbi’s Proven Care Program is designed to bring about weight loss through a personalized diet, nutrition, and wellness plan.
Followers of the Digbi Proven Care Program lost an average of 19.5 pounds (approx. 8.9 kilograms).
Here’s how Digbi’s Proven Care personalized plans reduce Obesity and affect health problems in various systems:
Gut-related disorders
0-80% of our body’s immune cells reside in our gut. The gastrointestinal system, in particular, the gut microbiota, remains a key playerin the complex mechanisms of our immune system, our body’s “defense mechanism” against various pathogens. Any imbalances in the population or composition of the gut microbiota are referred to as “gut dysbiosis” and can lead to dysregulated immune responses, causing our immune system to attack our own intestinal mucosa.
Individuals who followed the Digbi Health program saw an 80% reduction in the severity of Irritable bowel syndrome (IBS) and acid reflux.
Cardiovascular disease
Cardiovascular disease is the leading cause of morbidity and mortality among individuals with type 2 diabetes, accounting for 68% of all diabetic deaths. Genetic and lifestyle factors are associated with susceptibility to coronary artery disease.
Women with diabetes have been found to have a 44% greater risk of incident coronary heart disease and a 27% greater risk of stroke compared with men with diabetes. Diabetes is associated with a higher risk of venous thromboembolism and sudden cardiac death. It is also associated with a 24% higher risk of atrial fibrillation and a greater than a two-fold risk of death from vascular causes.
Despite advances in pharmacotherapy, diet and lifestyle still remain the cornerstone in preventing cardiovascular complications among those with type 2 diabetes.
Furthermore, a highly personalized wellness program such as Digbi’s can reduce Obesity plus diabetes and other comorbidities, and lower the risk of coronary events.
Musculoskeletal system
Being overweight or obese can put a lot of strain on the joints in the body and is one of the major causes of osteoarthritis (OA). Obese individuals are 1.5 times more likely to develop arthritis. Obese employees have a very high musculoskeletal risk, 300%. Every 5-unit increase in BMI results in an added 35% risk of knee OA and an 11% risk of hip OA.
Losing weight, even 10% of it, has been shown to reduce the strain on joints and related pain. As part of the same study, it was observed that those who lost 20% or more of their body weight saw an additional 25% drop in some osteoarthritis disease markers.
68% of Digbi’s Proven Care Program followers saw an improvement in their comorbidities. 65% experienced a reduction in the amount of medication needed to manage their comorbidities, as well as a 45% reduction in out-of-pocket payment.
40% of those enrolled in the Digbi Proven Care program hoped to see an improvement or reversal in chronic musculoskeletal pain. They experienced a 66% reduction in chronic pain via the program.
Along with guided exercise, Digbi’s Proven Care personalized nutrition and wellness program designed based on your genetic profile and gut microbiome profile can be a great tool in fighting Obesity and reducing comorbidities.
